
What happened
Corning reports Q3 before the open on Oct. 27, with shares down 19.93% over the past month and at about 38x 2026 consensus EPS, after five straight EPS beats and three straight earnings-day drops.
Why it matters
Revenue is the weak spot — Corning missed consensus in each of the last four quarters, and a clear revenue beat plus a firm Q4 guide would give the AI fiber story new credibility, JPMorgan analysts said.
Summaries like this, every morning.
Corning enters this report with an unusual pattern: the company keeps beating on earnings, but the stock keeps selling off on the day. Last quarter, core EPS of $0.78 beat the $0.7538 estimate for a fifth consecutive beat, yet revenue of $4.505 billion fell short of the $4.63 billion consensus even after growing 16.6%. Shares dropped 12.1% on earnings day, then rebounded 26.89% over the following week — a reminder that the market's reaction has been about revenue and outlook, not the bottom line.
The Optical Communications segment is what holds up the valuation. It posted $2.072 billion in sales, up 32%, with Enterprise Networks up 65% on Gen AI demand. CEO Wendell Weeks said in July that orders are accelerating and that results reflect scale-out only, with scale-up and photonics still ahead. Whether Optical holds 30%-plus growth — and whether new hyperscaler deals join those with Meta Platforms, Amazon and NVIDIA — is the central question for the quarter.
Solar and spending add secondary tests. The solar segment posted a $7 million net loss after a wafer shutdown added $30 million of expense versus Q1, and the $3 billion revenue target remains the measure there. Corning also expects capital spending to rise in Q3 and Q4, with about $2 billion committed this year, while handheld units are expected to fall by a mid-teens percentage and Carrier sales grew just 1% in Q2. JPMorgan analysts said strong Q3 revenue could put Corning on track to reach its $20 billion run-rate target ahead of schedule, which makes the Q4 outlook as important as the quarter itself.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
S&P Global reports Q3 on Oct

Tempus AI expanded its drug development collaborations with Bristol Myers Squibb and Pathos AI

Vertiv and NVIDIA presented at GTC on how they can halve AI factory deployment time

Danaher (DHR) received FDA clearance for AI-powered atrial fibrillation detection

CVS Health appointed Jack Hanlon, who previously held senior data and analytics roles at Meta and Reddit, as s…

T-Mobile US completed what Nvidia described as the first AI-RAN call on a live commercial network, unveiled at…
